Navigation Links
Rubicon Genomics Reports Surge In 2013 Sales Of Its Nucleic Acid Library Prep Kits

ANN ARBOR, Mich., Dec. 23, 2013 /PRNewswire/ -- Rubicon Genomics, Inc.,(Rubicon) today reported major gains in 2013 sales of its nucleic acid library preparation products, ThruPLEX®-FD Prep Kits and PicoPLEX™ WGA Kits, resulting in an increase in company revenues of 85%. 

James Koziarz, PhD, CEO of Rubicon Genomics, commented, "This has been a breakout year for Rubicon, as our expanded marketing efforts and use of our DNA prep kits in high visibility scientific publications have made more researchers aware of the advantages of our technology. Our patented ThruPLEX and PicoPLEX kits enable high quality sequencing of research and clinical samples that previously were too small or too degraded for testing."

In the past year, Rubicon technology has been used in studies featured in such publications as Nature1, Nature Genetics2 and Nature Methods3. The Nature study was the first to show that exomes sequenced from patient plasma could serve as a non-invasive biopsy to track the evolution of cancer in response to therapy, and ThruPLEX-FD was intrinsic to the success of that effort.

Dr. Koziarz continued, "Increased sales have allowed us to expand our resources to better serve our customers, including adding noted NGS researcher Dr. Kamran Shazand to lead our applications team. They also have generated production efficiencies that are enabling us to reduce prices in 2014, with the goal of ensuring broad access to Rubicon kits as we continue to grow our network of global distributors."

ThruPLEX-FD Prep Kits for Illumina® NGS platforms provide sensitive and consistent sequencing from challenging samples containing very small amounts of DNA or degraded DNA, delivering rapid sequencing of plasma, formalin-fixed, ChIP and other fragmented DNA samples with increased throughput. ThruPlex-FD employs a highly efficient, user-friendly process that uses a single tube and requires less than two hours. 

PicoPLEX-WGA Kits amplify DNA to yield a highly reproducible library from single cells with input concentrations as low as 15 picograms, producing DNA for analyses where accuracy and reproducibility are important. The easy-to-use single tube protocol reduces handling errors and background and dramatically improves time to results. The product is used in research and clinical applications and has been widely adopted in IVF pre-implantation screening.

1. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Muhammed Murtaza, et al. Nature 497, 108-112 doi:10.1038/nature12065
2. Large conserved domains of low DNA methylation maintained by Dnmt3a. Jeong, Mira, et al. Nature Genetics (2013) doi:10.1038/ng.2836
3. Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification. He, Housheng Hansen, et al. Nature Methods (2013) doi:10.1038/nmeth.2762

About Rubicon Genomics
Rubicon Genomics, Inc. is a leader in the development and commercialization of innovative sample-specific nucleic acid library preparation products used in research and clinical testing on NGS, microarray, and q-PCR platforms. The company creates efficient molecular biology tools for genetic, epigenetic and expression analysis of difficult samples to facilitate gene-based research, drug development and diagnostics.  Privately-held Rubicon is located in Ann Arbor, Michigan. For more information, visit

Media Rubicon Genomics

Barbara Lindheim Jamie Wibbenmeyer, PhD

BLL Partners, LLC Business Development

(212) 584-2276

SOURCE Rubicon Genomics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Rubicon Genomics Expands Distribution in Europe and Asia
2. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
3. Catching up with the Genomic Era in Oncology: Key Considerations for Incorporating Genomics into Oncology Drug Development, a New and Upcoming Webinar Hosted by Xtalks
4. Tute Genomics appoints Dr. Mingfu Zhu as Director of Bioinformatics
5. BioNano Genomics Announces the Adoption of Irys System by the Garvan Institute of Medical Research
6. Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization
7. Healthcare VC Dr. Dinesh Patel to serve on Tute Genomics Board of Directors
8. Tute Genomics Launches at 2013 ASHG Conference
9. BioNano Genomics Announces The Purchase Of The Irys System By The Chinese Academy Of Sciences And Tel Aviv University
10. NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing
11. Claritas Genomics to Sequence Exomes for VA Million Veteran Program with Ion Torrent Next-Generation Sequencers
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):